Zobrazeno 1 - 5
of 5
pro vyhledávání: '"A. S.R. van Lindert"'
Autor:
Mathijs L. Tomassen, Jacquelien Pomp, Janneke van der Stap, Anne S.R. van Lindert, Max Peters, José S.A. Belderbos, Dirk K.M. De Ruysscher, Steven H. Lin, Joost J.C. Verhoeff, Peter S.N. van Rossum
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 145-152 (2022)
Background: Prophylactic cranial irradiation (PCI) for limited-stage small-cell lung cancer (LS-SCLC) patients has become more controversial. Since the publication of the systematic review by Aupérin et al. in 1999, no randomized controlled trials r
Externí odkaz:
https://doaj.org/article/6248a69e1fe54b6c8437480ee66ed65a
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 621-624 (2019)
In locally advanced non-small cell lung cancer (NSCLC) patients, consolidation therapy with durvalumab (an anti-PD-L1 monoclonal antibody) has proven to significantly increase both progression free and overall survival after chemoradiotherapy. Here,
Externí odkaz:
https://doaj.org/article/0a95b2405224408f93ca666283bbf848
Autor:
Mick J.M. van Eijs, Rik J. Verheijden, Stefanie A. van der Wees, Stefan Nierkens, Anne S.R. van Lindert, Karijn P.M. Suijkerbuijk, Femke van Wijk
Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape of advanced malignancies, but come with a diverse spectrum of immune-related adverse events (irAEs). Mechanistic studies can aid the transition from expert-opinion to evid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d5acbd062750133be7bbef26afde31f
https://doi.org/10.1101/2023.01.20.23284818
https://doi.org/10.1101/2023.01.20.23284818
Autor:
F. Terhegggen, G. P. Bootsma, Hans M. Westgeest, Jessica S.W. Borgers, Daphne W. Dumoulin, M. Cloos, J. W. G. van Putten, John B. A. G. Haanen, C. J. van Loenhout, W. K. de Jong, I. Houtenbos, G. A. Cirkel, Otto Visser, J. C. Drooger, R. A.W. van de Wetering, T. J.N. Hiltermann, B. van den Borne, F. S. van der Meer, V. J.A.A. Nuij, Esther Oomen-de Hoop, C. H. van der Leest, Hanneke W. M. van Laarhoven, A. Becker-Commissaris, S. C.van t. Westeinde, A. P. Hamberg, L. van Leeuwen, A. S.R. van Lindert, B. W. Bouter, Rutger H. T. Koornstra, F. J. Borm, C. H. Rikers, E. A. Kastelijn, B. M.J. Scholtes, Y. Klaver, E. J.M. Siemerink, D. M. van Diepen, A. L. Peerdeman, Mieke J. Aarts, K. H. Herbschleb, V. E.M. van den Boogaart, Karijn P M Suijkerbuijk, G. Douma, S. D. Bakker, Karlijn de Joode, A. J. Staal, M. P.L. Bard, J. A. Stigt, C. C.M. Pitz, L. J. C. van Warmerdam, E. Looysen, Laurens V. Beerepoot, P. Brocken, C. R. van Rooijen, N. J.M. Claessens, Haiko J. Bloemendal, A.J. van de Wouw, Astrid A M van der Veldt, E. Citgez, Franchette W P J van den Berkmortel, M. Youssef, E. J. Geraedts, Nico G.J. van Diemen, G. L. Veurink, E. J. Libourel, N. P. Barlo, Elisabeth G.E. de Vries, J.W.B. de Groot, Anne-Marie C. Dingemans, W. H. van Geffen, G. J.M. Herder, Pim G N J Mutsaers, L. Strobbe, Jolien Tol, R. Heller, L. M. Faber, B. Franken, Lizza E.L. Hendriks, Mathilde Jalving, O. C.J. Schuurbiers-Siebers, B. C.M. Haberkorn, M. A. Tiemessen, M. Slingerland
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 141, pp. 171-184
European Journal of Cancer, 141, 171-184
European Journal of Cancer, 141, 171-184. Elsevier Limited
European Journal of Cancer, 141, 171-184. ELSEVIER SCI LTD
European Journal of Cancer, 141, 171-184. Elsevier Ltd.
European Journal of Cancer, 141, pp. 171-184
European Journal of Cancer, 141, 171-184
European Journal of Cancer, 141, 171-184. Elsevier Limited
European Journal of Cancer, 141, 171-184. ELSEVIER SCI LTD
European Journal of Cancer, 141, 171-184. Elsevier Ltd.
Aim of the study Patients with cancer might have an increased risk for severe outcome of coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse outcome of COVID-19, a nationwide registry was developed for patients with
Autor:
Pieter A. Doevendans, Alexander M. de Vos, Anne S.R. van Lindert, Matthijs F.L. Meijs, Petra M. Gorter, Yolanda van der Graaf, Mathias Prokop, Frank L.J. Visseren
Publikováno v:
Atherosclerosis. 197(2)
Objective Adipose tissue surrounding coronary arteries may contribute to the development of coronary atherosclerosis given its localisation and potential for local production of inflammatory cytokines. We compared various measurements for quantifying